Roche Diagnostics International AG
Roche Diagnostics International AG, a leading entity in the global healthcare sector, is headquartered in Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in diagnostics, focusing on innovative solutions that enhance patient care. The company operates extensively across Europe, North America, and Asia, providing cutting-edge diagnostic tools and services. Roche's core offerings include molecular diagnostics, tissue diagnostics, and point-of-care testing, distinguished by their accuracy and reliability. The company is renowned for its commitment to research and development, which has led to significant advancements in personalised healthcare. With a strong market position, Roche Diagnostics is celebrated for its contributions to early disease detection and management, solidifying its reputation as a trusted leader in the diagnostics industry.
DitchCarbon Score
How does Roche Diagnostics International AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Roche Diagnostics International AG's score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Roche Diagnostics International AG's reported carbon emissions
In 2022, Roche Diagnostics International AG reported total greenhouse gas emissions of approximately 73,000 kg CO2e, which are classified under Scope 1 and 2 emissions. This figure reflects a significant reduction from 2004, when emissions were about 100,000 kg CO2e, indicating a positive trend in their climate performance. Roche Diagnostics is part of a corporate family that includes Roche Holding AG, which influences its climate commitments and reporting. However, there are currently no specific reduction targets or initiatives disclosed by Roche Diagnostics International AG, nor are there any commitments to the Science Based Targets initiative (SBTi) or other climate pledges. The company’s emissions data and climate strategies are cascaded from its parent organization, Roche Holding AG, which is responsible for broader sustainability initiatives within the group. As a current subsidiary, Roche Diagnostics aligns its practices with the overarching goals set by its parent company, although specific targets for emissions reduction have not been detailed. Overall, Roche Diagnostics International AG demonstrates a commitment to reducing its carbon footprint, as evidenced by the decrease in emissions over the years, while continuing to align with the sustainability objectives of its parent company.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Roche Diagnostics International AG is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
